Cart
This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
Deleting

No Items In Cart
You’re under pressure to get your molecule to market as fast as possible, with as little risk and cost as possible, so you can maximize market share and revenue. But there are significant shifts that are changing the way in which new drugs are developed.
The IV-to-SC trend is increasing
The patient experience Is increasingly critical.
The competition is Intensifying
Question : In a survey of 488 patients, what percentage prefer subcutaneous (SC) injection over intravenous (IV) therapy?
Choose an option from right side.
Sorry, try again!
You are correct!
Clearly, choice of delivery mechanism has a significant impact on patient experience.
Sorry, try again!
Alternative therapies that solve a similar clinical problem but with a better delivery system can quickly gain an advantage, Which can increase your risk of market success.
You need to modernize your delivery by using technology to enable fit-for-purpose, on-body devices and simplify the development process so you can protect your market position.
To do that, you need to overcome two main challenges :
Which of the following are you feeling most acutely today?